Interrelation between compensation of carbohydrate metabolism and severity of manifestations of oxidative stress in type II diabetes mellitus

Bulletin of Experimental Biology and Medicine

Volumn 136, Issue 2, 2003, Pages 132-134

  Nedosugova, L V ^a   Lankin, V Z ^b   Balabolkin, M I ^a   Konovalova, G G ^b   Lisina, M O ^a   Antonova, K V ^a   Tikhaze, A K ^b   Belenkov, Yu N ^b  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Antioxidants; Free radical oxidation; Low density lipoproteins; Probucol; Type II diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; ANTIOXIDANT; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; LIPID HYDROPEROXIDE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; METFORMIN; PROBUCOL; REACTIVE OXYGEN METABOLITE; SULFONYLUREA; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ENZYME DEGRADATION; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; OXIDATIVE STRESS;

AGED; ANTIOXIDANTS; CARBOHYDRATE METABOLISM; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROBUCOL; REACTIVE OXYGEN SPECIES;

EID: 1642554674     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026302520288     Document Type: Article

References (14)

1. N. K. Zenkov, V. Z. Lankin, and E. B. Men'shchikova, Oxidative Stress. Biochemical and Pathophysiological Aspects [in Russian], Moscow (2001).
2. G. G. Konovalova, V. Z. Lankin, A. K. Tikhaze, et al., Byull. Eksp. Biol. Med., 136, No. 7, 49-52 (2003).
3. V. Z. Lankin, V. P. Lupanov, A. A. Lyakishev, and V. M. Revenko, Kardiologiya, 31, No. 6, 87-90 (1991).
4. V. Z. Lankin, A. K. Tikhaze, and Yu. N. Belenkov, Ibid., 40, No. 7, 48-61 (2000).
5. L. V. Nedosugova, A. K. Volkovoi, I. A. Rud'ko, et al., Klin. Farmakol. Ter., 9, No. 4, 65-67 (2000).
6. J. W. Baynes, Diabetes, 40, 405-412 (1991).
7. H. Esterbauer, R. J. Schaur, and H. Zollner, Free Radic. Biol. Med., 11, 81-128 (1991).
8. M. Hicks, L. Delbridge, D. K. Yue, et al., Arch. Biochem. Biophys., 268, 249-254 (1989).
9. E. Ho and T. M. Bray, Proc. Soc. Exp. Biol. Med., 222, 205-213 (1999).
10. J. V. Hunt, M. A. Bottoms, K. Clare, et al., Biochem. J., 300, 243-249 (1994).
11. D. W. Laight, M. J. Carrier, and E. E. Anggard, Cardiovasc. Res., 47, 457-464 (2000).
12. J. Nourooz-Zadeh, J. Tajaddini-Sarmadi, and S. R. Wolff, Analyt. Biochem., 220, 403-409 (1994).
13. N. B. Ruderman and C. Haudtnschild, Prog. Cardiovasc. Dis., 26, 373-412 (1984).
14. UKPDS, Lancet, 352, 854-865 (1998).